Picture of Trident Texofab logo

540726 Trident Texofab Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapNeutral

Annual cashflow statement for Trident Texofab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line15.39.0412.727.311.7
Depreciation
Amortisation
Non-Cash Items26.81931.726.841.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-80.6-18.6-45.2-12-42.5
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-28.519.613.958.527.1
Capital Expenditures-17.1-99.2-41.6-2.17-0.575
Purchase of Fixed Assets
Other Investing Cash Flow Items-7.01-2.78-2.245.89-5.14
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-24.1-102-43.83.73-5.71
Financing Cash Flow Items-24.7-8.87-21.3-33.9-37.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities49.581.929.9-62-20.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.07-0.4740.0430.2290.941